Jude Onyia, Chief Scientific Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 40,724 shares at $130.13 ($5.3M) on 2025-07-02, disclosed to the SEC on 2025-07-07.
Scheduled sale ($5.3M) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $130.13 | 20,362 | $2.6M | 50.0% |
| 2 | $130.13 | 20,362 | $2.6M | 50.0% |
| Total | $130.13 avg | 40,724 | $5.3M | 100% |
| Filing → |
| NBIX | SELL | 2025-07-11 | $15.6M | — | Filing → |
| NBIX | SELL | 2025-02-14 | $672K | — | Filing → |
| NBIX | SELL | 2025-02-04 | $19K | — | Filing → |